No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs182896820 |
chr11:86510150-86510151 |
Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs527397042 |
chr11:86510155-86510156 |
Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs375989474 |
chr11:86510159-86510160 |
Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs185706783 |
chr11:86510174-86510175 |
Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs560929928 |
chr11:86510175-86510176 |
Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs2105587 |
chr11:86510182-86510183 |
Weak transcription Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
7 |
rs190177369 |
chr11:86510203-86510204 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs73520709 |
chr11:86510208-86510209 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs148580129 |
chr11:86510223-86510224 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs182868342 |
chr11:86510248-86510249 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs565705006 |
chr11:86510264-86510265 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs188184143 |
chr11:86510282-86510283 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs141802149 |
chr11:86510298-86510299 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs76534442 |
chr11:86510302-86510303 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs872619 |
chr11:86510340-86510341 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs370522742 |
chr11:86510371-86510372 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs557396796 |
chr11:86510374-86510375 |
Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs373804786 |
chr11:86510402-86510403 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs142992782 |
chr11:86510410-86510411 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs192450025 |
chr11:86510465-86510466 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs531540674 |
chr11:86510474-86510475 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs73520713 |
chr11:86510551-86510552 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs182787500 |
chr11:86510564-86510565 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs142425319 |
chr11:86510576-86510577 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs375589492 |
chr11:86510579-86510580 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs146639801 |
chr11:86510587-86510588 |
Flanking Bivalent TSS/Enh Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs561028944 |
chr11:86510621-86510622 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs72969422 |
chr11:86510623-86510624 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs141894504 |
chr11:86510723-86510724 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs570077939 |
chr11:86510727-86510728 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs201333376 |
chr11:86510728-86510729 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs188067314 |
chr11:86510736-86510737 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs571459103 |
chr11:86510755-86510756 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs3809048 |
chr11:86510783-86510784 |
Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs547649814 |
chr11:86510857-86510858 |
Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs532291736 |
chr11:86510858-86510859 |
Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs552004558 |
chr11:86510915-86510916 |
Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs565743507 |
chr11:86510918-86510919 |
Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs534685898 |
chr11:86510926-86510927 |
Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs78697368 |
chr11:86511086-86511087 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs568519198 |
chr11:86511152-86511153 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs537281527 |
chr11:86511153-86511154 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs557544742 |
chr11:86511178-86511179 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs113412840 |
chr11:86511185-86511186 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs528997463 |
chr11:86511221-86511222 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs12787345 |
chr11:86511242-86511243 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs553664308 |
chr11:86511316-86511317 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs11604191 |
chr11:86511350-86511351 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs541019192 |
chr11:86511358-86511359 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs560850144 |
chr11:86511360-86511361 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|